Call Options Transactions Made in Q2 2023 in Intercept Pharmaceuticals, Inc. (ICPT)
This table provides information about the institutional ownership of Intercept Pharmaceuticals, Inc. (ICPT) during Q2 2023. The information is specifically focused on institutions that hold call options of INTERCEPT PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
BUY
|
CALL |
91.9K+ 314.73% |
$843K - $1.77M
|
121K
$0
|
|
|
Aug 11, 2023
Q2 2023
|
Dg Capital Management, LLC
New York, NY |
BUY
|
CALL |
74.3KNew |
$681K - $1.43M
|
74.3K
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
74.1K+ 66.28% |
$679K - $1.43M
|
186K
$0
|
|
|
Aug 23, 2023
Q2 2023
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
21.3KNew |
$195K - $411K
|
21.3K
$0
|
|
|
Aug 03, 2023
Q2 2023
|
Fifth Lane Capital, LP
Austin, TX |
BUY
|
CALL |
10KNew |
$91.7K - $193K
|
10K
$0
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-20.6K- 8.74% |
$189K - $397K
|
215K
$0
|